Acetylcholine production by group 2 innate lymphoid cells promotes mucosal immunity to helminths
Author(s) -
Luke B. Roberts,
Corinna Schnoeller,
Rita Berkachy,
Matthew Darby,
Jamie Pillaye,
Menno J. Oudhoff,
N. Parmar,
Claire Mackowiak,
Delphine Sedda,
Valérie Quesniaux,
Bernhard Ryffel,
Vaux Rachel,
Kleoniki Gounaris,
Sylvie Berrard,
David R. Withers,
William Horsnell,
Murray E. Selkirk
Publication year - 2021
Publication title -
science immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.83
H-Index - 51
ISSN - 2470-9468
DOI - 10.1126/sciimmunol.abd0359
Subject(s) - innate lymphoid cell , innate immune system , immunology , biology , immunity , immune system , acetylcholine , lymphatic system , helminths , lymphopoiesis , microbiology and biotechnology , endocrinology , stem cell , haematopoiesis
Innate lymphoid cells (ILCs) are critical mediators of immunological and physiological responses at mucosal barrier sites. Whereas neurotransmitters can stimulate ILCs, the synthesis of small-molecule neurotransmitters by these cells has only recently been appreciated. Group 2 ILCs (ILC2s) are shown here to synthesize and release acetylcholine (ACh) during parasitic nematode infection. The cholinergic phenotype of pulmonary ILC2s was associated with their activation state, could be induced by in vivo exposure to extracts of Alternaria alternata or the alarmin cytokines interleukin-33 (IL-33) and IL-25, and was augmented by IL-2 in vitro. Genetic disruption of ACh synthesis by murine ILC2s resulted in increased parasite burdens, lower numbers of ILC2s, and reduced lung and gut barrier responses to Nippostrongylus brasiliensis infection. These data demonstrate a functional role for ILC2-derived ACh in the expansion of ILC2s for maximal induction of type 2 immunity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom